申请人:Nucorion Pharmaceuticals, Inc.
公开号:US20160354399A1
公开(公告)日:2016-12-08
In accordance with the purpose(s) of the invention, as embodied and broadly described herein, the invention, in one aspect, relates to substituted gemcitabine aryl amide analogs, methods of making the same, pharmaceutical compositions comprising same, methods of treating viral disorders and disorders of uncontrolled cellular proliferation using same.